173 related articles for article (PubMed ID: 37046586)
1. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046586
[TBL] [Abstract][Full Text] [Related]
2. Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.
Ho SY; Liu PH; Hsu CY; Tseng HT; Huang YH; Su CW; Hou MC; Huo TI
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069310
[TBL] [Abstract][Full Text] [Related]
3. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
[TBL] [Abstract][Full Text] [Related]
4. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
5. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
Hu K; Yuan J; Tang B; Zhang F; Lu S; Chen R; Zhang L; Ren Z; Yin X
Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864
[TBL] [Abstract][Full Text] [Related]
6. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
Lee SK; Song MJ; Kim SH; Park M
PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
[TBL] [Abstract][Full Text] [Related]
7. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
[TBL] [Abstract][Full Text] [Related]
8. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
Khabbaz RC; Lokken RP; Chen YF; Lipnik AJ; Bui JT; Ray CE; Gaba RC
Cardiovasc Intervent Radiol; 2018 Jul; 41(7):1029-1034. PubMed ID: 29516241
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Ho SY; Liu PH; Hsu CY; Hsia CY; Lee YH; Lee RC; Huang YH; Lee FY; Hou MC; Tsai YJ; Huo TI
PLoS One; 2017; 12(7):e0180408. PubMed ID: 28672011
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade.
Liao JI; Ho SY; Liu PH; Hsu CY; Huang YH; Su CW; Hou MC; Huo TI
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765711
[TBL] [Abstract][Full Text] [Related]
11. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis.
Oikonomou T; Goulis L; Doumtsis P; Tzoumari T; Akriviadis E; Cholongitas E
Ann Hepatol; 2019; 18(1):126-136. PubMed ID: 31113581
[TBL] [Abstract][Full Text] [Related]
12. Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin grade: A Preliminary Study.
Huang Z; Zuo M; Ni J; Gu Y; Zhang T; Jiang Y; Zhuo S; An C; Huang J
Cancer Manag Res; 2020; 12():1373-1385. PubMed ID: 32158269
[TBL] [Abstract][Full Text] [Related]
13. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract][Full Text] [Related]
14. To determine the prognostic value of the albumin-bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma.
Khalid MA; Achakzai IK; Hanif FM; Ahmed S; Majid Z; Luck NH
Gastroenterol Hepatol Bed Bench; 2019; 12(2):110-115. PubMed ID: 31191834
[TBL] [Abstract][Full Text] [Related]
15. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Yuan MH; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Wang CL; Hou MC; Huo TI
Scand J Gastroenterol; 2023 Jan; 58(1):61-69. PubMed ID: 35830511
[TBL] [Abstract][Full Text] [Related]
16. Performance status as a prognostic surrogate in hepatocellular carcinoma: Role of albumin-bilirubin and easy-albumin-bilirubin grade.
Liao JI; Ho SY; Hou MC; Liu PH; Hsu CY; Huo TI
J Chin Med Assoc; 2024 Feb; 87(2):156-162. PubMed ID: 38095597
[TBL] [Abstract][Full Text] [Related]
17. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408
[No Abstract] [Full Text] [Related]
18. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study.
Wu B; Hu X; Jin H; Zhou L; Zhang D; Man Z; Wang Y; Yang S; Pang Q; Liu H; Cui P
Medicine (Baltimore); 2019 Oct; 98(43):e17394. PubMed ID: 31651841
[TBL] [Abstract][Full Text] [Related]
19. Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia.
Man ZR; Gong XK; Qu KL; Pang Q; Wu BQ
World J Gastrointest Oncol; 2024 May; 16(5):1763-1772. PubMed ID: 38764822
[TBL] [Abstract][Full Text] [Related]
20. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):903-911. PubMed ID: 35999514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]